---
figid: PMC6250284__wnr-29-1544-g001
figlink: /pmc/articles/PMC6250284/figure/F1/
number: F1
caption: The nicotinamide adenine dinucleotide (NAD) synthesis pathway. The de novo
  NAD synthesis pathway generates NAD from the essential aromatic amino acid tryptophan.
  Nicotinic acid mononucleotide (NaMN) is converted to nicotinic acid adenine dinucleotide
  (NaAD) by nicotinamide mononucleotide adenylyltransferase (NMNAT). NaAD is then
  converted to NAD by NAD synthetase. There are three additional thee salvage pathways.
  Nicotinamide mononucleotide (NMN) is produced by nicotinamide phosphoribosyltransferase
  (NAMPT) from nicotinamide (NAM), and by nicotinamide riboside kinase (NRK) from
  nicotinamide riboside (NR). NMN is then converted to NAD by NMNAT. Alternatively,
  NAM is converted to nicotinic acid (NA) by nicotinamidase, and then NA is converted
  to NaMN by nicotinic acid phosphoribosyltransferase (NaPRT). P7C3-A20 is reported
  to acts as a small-molecule activator of the enzyme NAMPT within the bioenergetic
  NAD synthesis pathway.
pmcid: PMC6250284
papertitle: P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary
  neuronal culture.
reftext: Ciaran S. Hill, et al. Neuroreport. 2018 Dec 12;29(18):1544-1549.
pmc_ranked_result_index: '55981'
pathway_score: 0.937145
filename: wnr-29-1544-g001.jpg
figtitle: The nicotinamide adenine dinucleotide (NAD) synthesis pathway
year: '2018'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6250284__wnr-29-1544-g001.html
  '@type': Dataset
  description: The nicotinamide adenine dinucleotide (NAD) synthesis pathway. The
    de novo NAD synthesis pathway generates NAD from the essential aromatic amino
    acid tryptophan. Nicotinic acid mononucleotide (NaMN) is converted to nicotinic
    acid adenine dinucleotide (NaAD) by nicotinamide mononucleotide adenylyltransferase
    (NMNAT). NaAD is then converted to NAD by NAD synthetase. There are three additional
    thee salvage pathways. Nicotinamide mononucleotide (NMN) is produced by nicotinamide
    phosphoribosyltransferase (NAMPT) from nicotinamide (NAM), and by nicotinamide
    riboside kinase (NRK) from nicotinamide riboside (NR). NMN is then converted to
    NAD by NMNAT. Alternatively, NAM is converted to nicotinic acid (NA) by nicotinamidase,
    and then NA is converted to NaMN by nicotinic acid phosphoribosyltransferase (NaPRT).
    P7C3-A20 is reported to acts as a small-molecule activator of the enzyme NAMPT
    within the bioenergetic NAD synthesis pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NMNAT1
  - NAPRT
  - NRK
  - NAMPT
  - NAM
  - Tryptophan
  - NaMN
  - NAMPT
  - NAD
  - WLD
genes:
- word: NMNAT/WLDI
  symbol: NMNAT
  source: hgnc_alias_symbol
  hgnc_symbol: NMNAT1
  entrez: '64802'
- word: NAPRT
  symbol: NAPRT
  source: hgnc_symbol
  hgnc_symbol: NAPRT
  entrez: '93100'
- word: NRK
  symbol: NRK
  source: hgnc_symbol
  hgnc_symbol: NRK
  entrez: '203447'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
chemicals:
- word: NAM
  source: MESH
  identifier: C051625
- word: Tryptophan
  source: ''
  identifier: ''
- word: NaMN
  source: MESH
  identifier: D012964
- word: NAMPT
  source: MESH
  identifier: C085455
- word: NAD
  source: MESH
  identifier: D009243
diseases:
- word: WLD
  source: MESH
  identifier: C563003
figid_alias: PMC6250284__F1
redirect_from: /figures/PMC6250284__F1
figtype: Figure
---
